位置:首页 > 蛋白库 > NDH_STAA8
NDH_STAA8
ID   NDH_STAA8               Reviewed;         402 AA.
AC   Q2FZV7;
DT   15-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 1.
DT   03-AUG-2022, entry version 92.
DE   RecName: Full=Type II NADH:quinone oxidoreductase {ECO:0000303|PubMed:25849513};
DE            EC=1.6.5.9 {ECO:0000269|PubMed:26172206, ECO:0000269|PubMed:28801048, ECO:0000269|PubMed:29524843};
DE   AltName: Full=NDH-2 {ECO:0000303|PubMed:26172206};
GN   OrderedLocusNames=SAOUHSC_00878;
OS   Staphylococcus aureus (strain NCTC 8325 / PS 47).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=93061;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=NCTC 8325 / PS 47;
RA   Gillaspy A.F., Worrell V., Orvis J., Roe B.A., Dyer D.W., Iandolo J.J.;
RT   "The Staphylococcus aureus NCTC 8325 genome.";
RL   (In) Fischetti V., Novick R., Ferretti J., Portnoy D., Rood J. (eds.);
RL   Gram positive pathogens, 2nd edition, pp.381-412, ASM Press, Washington
RL   D.C. (2006).
RN   [2]
RP   COFACTOR, SUBUNIT, SUBCELLULAR LOCATION, AND CRYSTALLIZATION.
RC   STRAIN=NCTC 8325 / PS 47;
RX   PubMed=25849513; DOI=10.1107/s2053230x15005178;
RA   Rosario A.L., Sena F.V., Batista A.P., Oliveira T.F., Athayde D.,
RA   Pereira M.M., Brito J.A., Archer M.;
RT   "Expression, purification, crystallization and preliminary X-ray
RT   diffraction analysis of a type II NADH:quinone oxidoreductase from the
RT   human pathogen Staphylococcus aureus.";
RL   Acta Crystallogr. F Struct. Biol. Commun. 71:477-482(2015).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVITY REGULATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, SUBUNIT, SUBCELLULAR LOCATION, AND DOMAIN.
RC   STRAIN=NCTC 8325 / PS 47;
RX   PubMed=26172206; DOI=10.1111/mmi.13120;
RA   Sena F.V., Batista A.P., Catarino T., Brito J.A., Archer M., Viertler M.,
RA   Madl T., Cabrita E.J., Pereira M.M.;
RT   "Type-II NADH:quinone oxidoreductase from Staphylococcus aureus has two
RT   distinct binding sites and is rate limited by quinone reduction.";
RL   Mol. Microbiol. 98:272-288(2015).
RN   [4]
RP   REACTION MECHANISM, ACTIVE SITE, AND DOMAIN.
RX   PubMed=28181562; DOI=10.1038/srep42303;
RA   Marreiros B.C., Sena F.V., Sousa F.M., Oliveira A.S., Soares C.M.,
RA   Batista A.P., Pereira M.M.;
RT   "Structural and functional insights into the catalytic mechanism of the
RT   type II NADH:quinone oxidoreductase family.";
RL   Sci. Rep. 7:42303-42303(2017).
RN   [5]
RP   CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RC   STRAIN=NCTC 8325 / PS 47;
RX   PubMed=29524843; DOI=10.1016/j.redox.2018.02.004;
RA   Sena F.V., Sousa F.M., Oliveira A.S.F., Soares C.M., Catarino T.,
RA   Pereira M.M.;
RT   "Regulation of the mechanism of Type-II NADH: Quinone oxidoreductase from
RT   S. aureus.";
RL   Redox Biol. 16:209-214(2018).
RN   [6] {ECO:0007744|PDB:5NA1, ECO:0007744|PDB:5NA4}
RP   X-RAY CRYSTALLOGRAPHY (2.32 ANGSTROMS) OF WILD-TYPE AND MUTANT SER-172 IN
RP   COMPLEXES WITH FAD, FUNCTION, CATALYTIC ACTIVITY, COFACTOR, ACTIVE SITE,
RP   AND MUTAGENESIS OF GLU-172.
RC   STRAIN=NCTC 8325 / PS 47;
RX   PubMed=28801048; DOI=10.1016/j.bbabio.2017.08.002;
RA   Sousa F.M., Sena F.V., Batista A.P., Athayde D., Brito J.A., Archer M.,
RA   Oliveira A.S.F., Soares C.M., Catarino T., Pereira M.M.;
RT   "The key role of glutamate 172 in the mechanism of type II NADH:quinone
RT   oxidoreductase of Staphylococcus aureus.";
RL   Biochim. Biophys. Acta 1858:823-832(2017).
CC   -!- FUNCTION: Alternative, nonproton pumping NADH:quinone oxidoreductase
CC       that delivers electrons to the respiratory chain by oxidation of NADH
CC       and reduction of quinones, and contributes to the regeneration of
CC       NAD(+) (PubMed:26172206, PubMed:28801048). Can use DMN, a menaquinone
CC       analog, 2,3-dimethoxy-5,6-dimethyl-benzoquinone (DDB), an ubiquinone
CC       analog, or 2,3,5,6-tetramethyl-1,4-benzoquinone (Duroquinone, DQ) a
CC       plastoquinone analog as electron acceptors (PubMed:26172206).
CC       {ECO:0000269|PubMed:26172206, ECO:0000269|PubMed:28801048}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a quinone + H(+) + NADH = a quinol + NAD(+);
CC         Xref=Rhea:RHEA:46160, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:132124; EC=1.6.5.9;
CC         Evidence={ECO:0000269|PubMed:26172206, ECO:0000269|PubMed:28801048,
CC         ECO:0000269|PubMed:29524843};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a menaquinone + H(+) + NADH = a menaquinol + NAD(+);
CC         Xref=Rhea:RHEA:29235, Rhea:RHEA-COMP:9537, Rhea:RHEA-COMP:9539,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16374, ChEBI:CHEBI:18151,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000269|PubMed:26172206};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a ubiquinone + H(+) + NADH = a ubiquinol + NAD(+);
CC         Xref=Rhea:RHEA:23152, Rhea:RHEA-COMP:9565, Rhea:RHEA-COMP:9566,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16389, ChEBI:CHEBI:17976,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945;
CC         Evidence={ECO:0000269|PubMed:26172206};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:25849513, ECO:0000269|PubMed:26172206,
CC         ECO:0000269|PubMed:28801048};
CC       Note=Binds 1 FAD per subunit. {ECO:0000269|PubMed:26172206,
CC       ECO:0000269|PubMed:28801048};
CC   -!- ACTIVITY REGULATION: Inhibited by HQNO, a quinone derivative.
CC       {ECO:0000269|PubMed:26172206, ECO:0000269|PubMed:29524843}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=69.9 uM for DMN {ECO:0000269|PubMed:26172206};
CC         KM=63.7 uM for DDB {ECO:0000269|PubMed:26172206};
CC         KM=55.4 uM for DQ {ECO:0000269|PubMed:26172206};
CC         KM=20.5 uM for NADH {ECO:0000269|PubMed:26172206};
CC         Vmax=132.7 umol/min/mg enzyme with DMN as substrate
CC         {ECO:0000269|PubMed:26172206};
CC         Vmax=129.3 umol/min/mg enzyme with DDB as substrate
CC         {ECO:0000269|PubMed:26172206};
CC         Vmax=119.1 umol/min/mg enzyme with DQ as substrate
CC         {ECO:0000269|PubMed:26172206};
CC         Vmax=175.9 umol/min/mg enzyme with NADH as substrate
CC         {ECO:0000269|PubMed:26172206};
CC         Note=kcat is 67.9 sec(-1) with DMN as substrate. kcat is 69.4 sec(-1)
CC         with DDB as substrate. kcat is 68.2 sec(-1) with DQ as substrate.
CC         {ECO:0000269|PubMed:26172206};
CC   -!- SUBUNIT: Homodimer in solution (PubMed:25849513, PubMed:26172206).
CC       Forms homotetramers; dimer of dimers (PubMed:25849513,
CC       PubMed:26172206). {ECO:0000269|PubMed:25849513,
CC       ECO:0000269|PubMed:26172206}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:25849513,
CC       ECO:0000269|PubMed:26172206}. Note=Interacts with the membrane via an
CC       anti-parallel three-stranded beta-sheet followed by two helices
CC       arranged in a helix-turn-helix motif at the C-terminal region.
CC       {ECO:0000269|PubMed:26172206}.
CC   -!- DOMAIN: Contains a first dinucleotide binding domain, which harbors
CC       FAD, a second dinucleotide binding domain, which interacts with NADH
CC       and C-terminal domain that provides anchoring to the membrane
CC       (PubMed:28801048). A long discussion has taken place about whether NADH
CC       and the quinone bind to the same or to different sites. Structural
CC       studies clearly indicate the presence of distinct binding sites for the
CC       two substrates (PubMed:26172206, PubMed:28181562).
CC       {ECO:0000269|PubMed:26172206, ECO:0000269|PubMed:28181562,
CC       ECO:0000269|PubMed:28801048}.
CC   -!- SIMILARITY: Belongs to the NADH dehydrogenase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CP000253; ABD30003.1; -; Genomic_DNA.
DR   RefSeq; WP_000046076.1; NZ_LS483365.1.
DR   RefSeq; YP_499431.1; NC_007795.1.
DR   PDB; 5NA1; X-ray; 2.32 A; A=1-402.
DR   PDB; 5NA4; X-ray; 2.55 A; A=1-402.
DR   PDBsum; 5NA1; -.
DR   PDBsum; 5NA4; -.
DR   AlphaFoldDB; Q2FZV7; -.
DR   SMR; Q2FZV7; -.
DR   STRING; 1280.SAXN108_0936; -.
DR   EnsemblBacteria; ABD30003; ABD30003; SAOUHSC_00878.
DR   GeneID; 3919225; -.
DR   KEGG; sao:SAOUHSC_00878; -.
DR   PATRIC; fig|93061.5.peg.798; -.
DR   eggNOG; COG1252; Bacteria.
DR   HOGENOM; CLU_021377_7_2_9; -.
DR   OMA; DHCIFLD; -.
DR   PRO; PR:Q2FZV7; -.
DR   Proteomes; UP000008816; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0003955; F:NAD(P)H dehydrogenase (quinone) activity; IBA:GO_Central.
DR   GO; GO:0050136; F:NADH dehydrogenase (quinone) activity; IEA:RHEA.
DR   GO; GO:0019646; P:aerobic electron transport chain; IBA:GO_Central.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   SUPFAM; SSF51905; SSF51905; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; FAD; Flavoprotein; Membrane; NAD;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..402
FT                   /note="Type II NADH:quinone oxidoreductase"
FT                   /id="PRO_0000287371"
FT   ACT_SITE        172
FT                   /evidence="ECO:0000305|PubMed:28181562,
FT                   ECO:0000305|PubMed:28801048"
FT   BINDING         12..16
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   BINDING         39..40
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   BINDING         83
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   BINDING         302
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   BINDING         319..320
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   BINDING         379
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   MUTAGEN         172
FT                   /note="E->A: 3.4-fold decrease in kcat for DMN. Decreases
FT                   the overall affinity for NAD(+) and the quinone."
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   MUTAGEN         172
FT                   /note="E->D: Loss of activity."
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   MUTAGEN         172
FT                   /note="E->Q: 12-fold decrease in kcat for DMN. Decreases
FT                   the overall affinity for NAD(+) and the quinone."
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   MUTAGEN         172
FT                   /note="E->S: 6-fold decrease in kcat for DMN. Decreases the
FT                   overall affinity for NAD(+) and the quinone."
FT                   /evidence="ECO:0000269|PubMed:28801048"
FT   STRAND          6..11
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           15..27
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   TURN            30..32
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          33..45
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           47..49
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           50..55
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           60..63
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          64..67
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           68..70
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   TURN            73..75
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          76..80
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          83..87
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   TURN            88..91
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          92..95
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          98..101
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          103..107
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           121..124
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           131..150
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           156..159
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          160..164
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           168..188
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           192..194
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          196..200
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          202..207
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           212..224
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          227..230
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          235..239
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          242..247
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          250..255
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          257..261
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          265..267
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           270..274
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          275..279
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          282..284
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          289..291
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          294..299
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           301..303
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           319..337
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          351..355
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          357..359
FT                   /evidence="ECO:0007829|PDB:5NA4"
FT   STRAND          361..365
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   STRAND          368..371
FT                   /evidence="ECO:0007829|PDB:5NA1"
FT   HELIX           373..399
FT                   /evidence="ECO:0007829|PDB:5NA1"
SQ   SEQUENCE   402 AA;  44104 MW;  2C3DE4D5098C2D53 CRC64;
     MAQDRKKVLV LGAGYAGLQT VTKLQKAIST EEAEITLINK NEYHYEATWL HEASAGTLNY
     EDVLYPVESV LKKDKVNFVQ AEVTKIDRDA KKVETNQGIY DFDILVVALG FVSETFGIEG
     MKDHAFQIEN VITARELSRH IEDKFANYAA SKEKDDNDLS ILVGGAGFTG VEFLGELTDR
     IPELCSKYGV DQNKVKITCV EAAPKMLPMF SEELVNHAVS YLEDRGVEFK IATPIVACNE
     KGFVVEVDGE KQQLNAGTSV WAAGVRGSKL MEESFEGVKR GRIVTKQDLT INGYDNIFVI
     GDCSAFIPAG EERPLPTTAQ IAMQQGESVA KNIKRILNGE STEEFEYVDR GTVCSLGSHD
     GVGMVFGKPI AGKKAAFMKK VIDTRAVFKI GGIGLAFKKG KF
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024